BSECompany Update3 Nov 2026 · 3 Nov 2026, 07:20 pm
Please find attached herewith a copy of News Release that is being issued by the Company today.
Bayer CropScience Ltd · 506285
✦ AI SummaryResults
Bayer CropScience Limited reported its unaudited results for Q2 and H1 ended September 30, 2026, with revenue from operations declining 19% and 11% respectively, and profit before tax increasing 6% and 15% respectively.
Analysis Scores
Earnings Impact4/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Bayer CropScience Ltd - 506285 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Attachments (1)
📄pdf
Download →
856f0d7e-be06-44de-adf2-0ea023a56d6d.pdf
View document text
November 03, 2026
The General Manager
Department of Corporate Services
BSE Limited
Phiroze Jeejeebhoy Towers
Dalal Street
Mumbai – 400 001
COMPANY CODE : BAYERCROP
SCRIP CODE : 506285
Dear Sir / Madam, Bayer CropScience Ltd.
CIN: L24210MH1958PLC011173
Sub.: News Release - Unaudited Financial Results for the quarter and
Registered and Corporate Office:
half year ended on September 30, 2026. Bayer House
Central Avenue
Hiranandani Estate
We send herewith a copy of the News Release that is being issued by the
Thane (West) – 400 607
Company today, in connection with the captioned subject. Maharashtra, India
Tel : +91 22 2531 1234
You are requested to kindly take note of the same. Fax : +91 22 2545 5063
www.bayer.in
www.cropscience.bayer.com
Thanking You.
Yours faithfully,
for Bayer CropScience Limited
Bharati Shetty
Company Secretary and Compliance Officer
(Membership No.: ACS 24199)
Encl.: As above
RESTRICTED
Bayer CropScience Limited
Communications
Bayer House, Hiranandani Estate
Thane (West) - 400607
News Release
Maharashtra, India
www.bayer.in
Quarterly Results
Bayer CropScience Limited reports Q2 and H1 Results for FY 2026-27
Revenue from Operations of ₹12,507 million
Profit Before Tax of ₹2,114 million
Mumbai, November 03, 2026: Bayer CropScience Limited (BSE: 506285) announced today its unaudited
results for the quarter (Q2) and half year (H1) ended September 30, 2026.
For Q2 ended September 30, 2026, Bayer CropScience Limited (BCSL) registered Revenue from
Operations of ₹12,507 million as compared to ₹15,534 million in the corresponding period of FY 2025-
26, a decline of 19%. Profit Before Tax stood at ₹2,114 million, compared to ₹2,003 million in the
corresponding period of the previous financial year, an increase of 6%.
For the H1 ended September 30, 2026, BCSL reported Revenue from Operations of ₹30,857 million
compared to ₹34,680 million for the corresponding period in FY 2025-26, a decline of 11%. Profit Before
Tax for the H1 ended September 30, 2026, stood at ₹6,135 million, compared to ₹5,355 million for the
corresponding period in FY 2025-26, an increase of 15%.
Commenting on the quarterly results, Simon Wiebusch, Vice Chairman & Managing Director and CEO,
BCSL, said, “Q2 reflected a challenging operating environment, with an uneven monsoon affecting
sowing patterns and crop protection demand, alongside lower corn acreages. Against this backdrop, we
remained focused on disciplined execution, strengthening our portfolio and scaling new innovations. As
Indian agriculture navigates increasing volatility, our priority is to help farmers improve productivity and
resilience by bringing together innovations and partnerships across the agricultural ecosystem, while
building a stronger and more sustainable business for the long term.”
Vinit Jindal, Executive Director and Chief Financial Officer, Bayer CropScience Limited, added, “Profit
After Tax increased by 9% in Q2 and 13% in H1, supported by improved gross margins reflecting
favourable production yields for corn seeds and cost efficiencies. Higher corn seed production volumes,
combined with weaker market demand, resulted in increased inventory. Market liquidity pressures led to
delayed collections and marginally higher receivables. We remain focused on disciplined working capital
management and strengthening cash generation.”
The Board of Directors at its meeting held on November 03, 2026, declared an interim dividend of ₹ 90/-
per equity share for the financial year ending March 31, 2027, amounting to ₹ 4,045 million.
About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition.
In line with its mission, “Health for all, Hunger for none,” the company’s products and services are
designed to support efforts to master major challenges presented by a growing and aging global
1 / 2
RESTRICTED
population and create value through innovation and growth. The Bayer brand stands for trust, reliability
and quality throughout the world. In fiscal 2025, the Group employed around 88,000 people and had sales
of 45.6 billion euros. R&D expenses amounted to 5.8 billion euros. For more information, go to
www.bayer.com
Media Contact
Snigdha Vishal
Communications, Bayer CropScience Limited
E-mail: snigdha.vishal@bayer.com
Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management.
Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future
results, financial situation, development or performance of the company and the estimates given here. These factors include those
discussed in Bayer’s public reports, which are available on the Bayer website at www.bayer.com. The company assumes no liability
whatsoever to update these forward-looking statements or to conform them to future events or developments.
2 / 2
RESTRICTED